Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 4Sarcoma 2Triple Negative Breast Neoplasms 1Sarcoma, Synovial 1Pheochromocytoma 1Neurofibrosarcoma 1Neuroblastoma 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell 1Lymphoma 1Liposarcoma 1Leiomyosarcoma 1Inflammatory Breast Neoplasms 1Histiocytoma, Malignant Fibrous 1Hematologic Neoplasms 1Fibrosarcoma 1Breast Neoplasms, Male 1

Interventions

Therapeutics 2Specimen Handling 2Early Intervention, Educational 2pegfilgrastim 1cediranib 1X-Rays 1Palliative Care 1Neoadjuvant Therapy 1Methods 1Mastectomy, Segmental 1Mastectomy, Modified Radical 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1Indocyanine Green 1Hypnosis 1High-Energy Shock Waves 1Filgrastim 1Exercise Test 1Educational Status 1Doxorubicin 1Docetaxel 1Cyclophosphamide 1Clostridium perfringens epsilon-toxin 1Analgesia 1Accelerometry 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Inflammatory Breast Neoplasms × pegfilgrastim × Clear all
NCT00310089 2013-06-20

AZD2171 and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer

National Cancer Institute (NCI)

Phase NA Completed
33 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡